Innate Pharma SA
IPHA1.790USD
+0.040+2.29%
Close 12/22, 16:00（ET）Quotes delayed by 15 min
164.96MMarket Cap
LossP/E TTM
Innate Pharma SA Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
11.69M
-75.55%
EPS(YoY)
-0.59
-591.49%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Innate Pharma SA?
According to Innate Pharma SA's FY2024 earnings report, its total revenue reached 11.69M, with a year-on-year change of -75.55%.
What is the Earnings Per Share (EPS) of Innate Pharma SA?
According to Innate Pharma SA's FY2024 earnings report, its Earnings Per Share (EPS) was -0.590, with a year-on-year change of -591.49%.
What is the net income of Innate Pharma SA?
According to Innate Pharma SA's FY2024 earnings report, its net income was -45.80M, with a year-on-year change of -557.08%.
What is the net margin of Innate Pharma SA?
According to Innate Pharma SA's FY2024 earnings report, its net profit margin was -391.94%, with a year-on-year change of -2587.21%.
What is the gross margin of Innate Pharma SA?
According to Innate Pharma SA's FY2024 earnings report, its gross margin was 75.79%, with a year-on-year change of -19.80%.
What is the debt-to-asset ratio of Innate Pharma SA?
According to Innate Pharma SA's FY2024 earnings report, its debt-to-asset ratio was 71.64%, with a year-on-year change of 42.55%.
What is the Return on Equity (ROE) of Innate Pharma SA?
According to Innate Pharma SA's FY2024 earnings report, its Return on Equity (ROE) was -162.91%, with a year-on-year change of -1041.13%.
What is the Return on Assets (ROA) of Innate Pharma SA?
According to Innate Pharma SA's FY2024 earnings report, its Return on Assets (ROA) was -33.51%, with a year-on-year change of -767.78%.
What is the operating profit of Innate Pharma SA?
According to Innate Pharma SA's FY2024 earnings report, its operating profit was -47.75M, with a year-on-year change of -309.32%.
What are the current assets of Innate Pharma SA?
According to Innate Pharma SA's FY2024 earnings report, its current assets were 79.38M, with a year-on-year change of -46.37%.
What are the total assets of Innate Pharma SA?
According to Innate Pharma SA's FY2024 earnings report, its total assets of Innate Pharma SA were 102.82M, with a year-on-year change of -44.18%.
What are the total liabilities of Innate Pharma SA?
According to Innate Pharma SA's FY2024 earnings report, its total liabilities of Innate Pharma SA were 94.64M, with a year-on-year change of -28.46%.
What is the total equity of Innate Pharma SA?
According to Innate Pharma SA's FY2024 earnings report, its total equity of Innate Pharma SA was 8.18M, with a year-on-year change of -84.24%.
What is the net operating income of Innate Pharma SA?
According to Innate Pharma SA's FY2024 earnings report, its net operating income of Innate Pharma SA was -45.80M, with a year-on-year change of -557.08%.
What is the net investment of Innate Pharma SA?
According to Innate Pharma SA's FY2024 earnings report, its net investment of Innate Pharma SA was 8.52M, with a year-on-year change of -55.16%.
What is the net financing of Innate Pharma SA?
According to Innate Pharma SA's FY2024 earnings report, its net financing of Innate Pharma SA was -5.56M, with a year-on-year change of -207.26%.
